Next Article in Journal
Economic Evaluation of Pharmacopuncture for Adhesive Capsulitis Alongside a Pilot Pragmatic Randomized Controlled Trial Comparing Pharmacopuncture and Physical Therapy
Previous Article in Journal
Coping with Death Among Nurses in Ecuador: A Mixed-Methods Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Masculine Identity, Body Image and Illness-Related Shame: Pathways to Psychological Distress in Men with Fibromyalgia

1
School of Behavioral Sciences, The Academic College of Tel Aviv-Yaffo, Tel Aviv-Yaffo 6818211, Israel
2
Statistics Education Unit, The Academic College of Tel Aviv-Yaffo, Tel Aviv-Yaffo 6818211, Israel
*
Author to whom correspondence should be addressed.
Healthcare 2026, 14(5), 606; https://doi.org/10.3390/healthcare14050606
Submission received: 26 January 2026 / Revised: 21 February 2026 / Accepted: 24 February 2026 / Published: 27 February 2026

Abstract

Objective: Although recognition of fibromyalgia (FMS) in men is growing, the mechanisms that contribute to their psychological distress remain poorly understood. This study aims to clarify how FMS alters men’s psychological distress and to identify potential protective and risk factors involved in this process in this often-underrepresented population. Methods: This study comprised a total of 225 men aged 18–75; of these, 102 were men with FMS (based on self-report) and 123 were healthy peers (HPs), all of whom completed questionnaires on demographics, anxiety (GAD-7), depression (PHQ-9), body appreciation (BAS-2), masculine self-esteem (MSES), illness-related shame (CISS), and pain intensity (SF-MPQ). Results: Men with FMS reported significantly higher depression and anxiety, lower body appreciation, and compromised masculine identity. Between-group analysis showed body appreciation mediated the fibromyalgia–distress relationship. However, within the FMS group, compromised masculine identity and illness-related shame were the strongest pathways to distress, while body appreciation showed no effect. Moderation analysis confirmed body appreciation buffered distress in controls but not in men with FMS. Conclusion: Masculine identity threats and illness-related shame constitute central mechanisms of psychological distress in men with FMS. Body appreciation operates differently in this population than in healthy men. Findings underscore the need for gender-sensitive interventions addressing identity disruption and emphasizing functionality over appearance-based acceptance.

1. Introduction

Fibromyalgia syndrome is a chronic condition involving persistent, widespread pain with associated fatigue, stiffness, sleep disturbance, and functional impairment [1]. Anxiety and depression are highly prevalent and often exceed rates found in other chronic pain conditions and healthy populations [2]. Although reports estimated female-to-male ratio of FMS prevalence at 3:1 [3], growing evidence indicates that FMS is underdiagnosed in men due to diagnostic bias [4]. Gender norms and patterns of symptom reporting further widen this gap [5], placing men in what Conversano et al. [6] describe as a “double burden of credibility,” linked to both a contested diagnosis and the stigma of a condition perceived as feminine. This contributes to clinical skepticism [7], causing diagnostic delays, self-doubt [8], and reduced access to treatment, thus producing psychological consequences that remain insufficiently understood in men with FMS [9].
Men with fibromyalgia exhibit high anxiety and depression scores [10], often experiencing equal or greater psychological distress (PD) than women. Henao-Pérez et al. [11] identified male sex as a distinct risk factor, with depression and anxiety present in 42.6% of men compared to 28% of women with FMS. Contributing factors include the condition’s invisibility, which generates both a credibility and identity crisis that challenges masculine self-concept [12]; cognitive dysfunction that undermines competence and productivity [6]; loss of functional capacity in work and physical activities [9]; and sexual dysfunction, which further threatens self-esteem and intimate relationships [6].
In studies of women with FMS, evidence shows that while it is directly associated with PD, indirect mechanisms also contribute to this relationship [13,14]. Specifically, self-compassion and body appreciation were identified as protective factors against PD among women with FMS [14], while social comparison strategies mediated the link between FMS and PD [13]. The present study aims to develop an explanatory model for the effect of FMS on men’s PD, identifying the interplay between body appreciation, illness-related shame, and masculinity.

1.1. Body Image

Body image is a multifaceted psychological construct encompassing individuals’ perceptions and attitudes toward their bodies, including associated thoughts, beliefs, emotions, and behaviors [15]. This notion has received increasing attention in health-related research, with growing recognition of the importance of incorporating the embodied experiences, particularly experiences of pain and disability, into the understanding of body image [16].
One important dimension of body image is body appreciation, a positive aspect that refers to the unconditional acceptance, respect, and favorable evaluation of one’s body [17]. Body appreciation has been identified as a potential protective factor in the psychological wellbeing of individuals with chronic illnesses. For instance, across patient samples, greater body appreciation has been associated with better quality of life [18,19].
Women with fibromyalgia frequently report disturbed body image, including distrust of the body, functional limitations, reduced vitality, and weight concerns [20,21]. Even without visible deformity, the condition is consistently linked to negative perceptions of appearance and functionality and to heightened PD [21,22]. Pain severity is closely tied to poorer body appreciation, shaped by localized pain, cognitive symptoms, negative healthcare experiences, activity restrictions, and reduced quality of life [20,22]. Although women report slightly higher generalized pain and somatic symptoms, men show similar diagnostic profiles [4]. For men, fibromyalgia often triggers a sharp shift in bodily self-perception: from strength and reliability to vulnerability and loss of control [6,12]. This reflects both activity limitations [23] and a deeper rupture in bodily identity, with men describing their bodies as alien and untrustworthy [12]. Evidence on body appreciation in men with fibromyalgia is minimal. The only study testing gender as a moderator of the pain–body image link found no differences, suggesting similar mechanisms across genders [24]. More research is needed to determine whether body appreciation buffers PD in men with fibromyalgia.

1.2. Masculine Identity

Traditional masculine identity is closely tied to physical capability, including strength, endurance, functional competence, and sexual performance [25]. Because masculinity is a culturally contingent and often fragile construct [26], chronic illness can destabilize it. Fibromyalgia disrupts these embodied foundations, requiring what Conversano et al. [6] describe as an “inefficient renegotiation” of masculinity marked by perceived inadequacy. Loss of capacity for roles in physical labor, sport, and breadwinning weakens core identity anchors [12], a pattern also seen in other chronic conditions such as Lyme disease [27]. This threat extends beyond personal experience to societal perceptions: healthcare professionals and the public often view men with chronic pain as less masculine, attributing dependency and emotional vulnerability [28]. Given that fibromyalgia is culturally coded as a feminine condition, men face pressures to maintain provider roles and adhere to stoic norms that inhibit help seeking and emotional expression [7,29]. Many therefore avoid seeking help due to shame and perceived masculinity loss [6,12], increasing vulnerability to psychological distress across multiple domains.

1.3. Illness-Related Shame in FMS

Shame is an essential mechanism linking impaired body image to PD in men with fibromyalgia. Defined by global inadequacy and reduced self-worth [30], shame is strongly associated with depression and anxiety across chronic illness [31,32]. In chronic-pain populations, it can be more distressing than the pain itself [33], and shame proneness is markedly elevated compared to HPs [34]. Among men with fibromyalgia, shame arises through three interconnected pathways. Illness-related shame may arise when physical changes or symptoms are perceived as falling short of ideals of strength and capability. Both visible challenges and less apparent symptoms, such as sexual dysfunction or cognitive fog, can contribute to these feelings of shame [9]. Internalized stigma adds a second layer, as men identify with a doubly stigmatized category: chronic-pain patients and men with a condition culturally framed as feminine [6,35]. A third pathway, role performance shame, emerges when illness-related limitations undermine traditional roles as provider, protector, or sexually capable partner, eroding self-worth [23]. Disrupted body image may therefore contribute to the development of illness-related shame, which in turn can intensify disruptions in gender role expectations and lead to heightened levels of depression and anxiety, underscoring the need for gender-sensitive interventions.

1.4. Pain

Chronic and diffuse pain is the core symptom of FMS [1], and heightened perception of pain has been found associated with high levels of anxiety and depression [13]. Drawing on the developmental theory of embodiment and fibromyalgia-specific literature, lived pain experiences in FMS shape body image [24]. Threats to masculine identity and illness-related shame, both linked to pain experiences, may mediate the development of anxiety and depression in men with FMS [7,12].
Thus, the overarching goal of the current study is to identify the roles and the interplay between body appreciation, illness-related shame, masculine identity and pain, in the manifestation of PD in men with FMS.
Within this context, the hypotheses of our study are as follows:
Hypothesis 1: 
Group differences
H1a: 
Men with FMS will present higher PD, compromised sense of masculinity, and lower body appreciation than HPs.
H1b: 
PD will be positively correlated with loss of masculinity and negatively correlated with body appreciation. In turn, body appreciation will be negatively correlated with compromised masculinity.
H1c: 
Body appreciation, followed by compromised masculinity, will mediate the link between FMS and PD (Figure 1).
Hypothesis 2: 
Among men with FMS
H2a: 
Illness characteristics—pain, illness-related shame, and compromised sense of masculinity—will be positively correlated with PD. Body appreciation will be negatively related to PD.
H2b: 
Body appreciation, followed by illness-related shame and then compromised masculinity, will mediate the link between pain and PD (Figure 2).

2. Materials and Methods

This cross-sectional survey was carried out in Israel from 2023 to 2024. Participants were recruited via relevant online forums and a snowball sampling, according to which research assistants approached potential participants among their acquaintances who, in turn, were asked to help recruit more participants. The study was approved by the Institutional Review Board (IRB) of The Academic College of Tel-Aviv Yaffo (# 2023315 on 16 December 2023). Participants provided informed consent and were assured that the questionnaire was completely anonymous and that they could discontinue participation at any time.
Inclusion criteria were men aged over 18 who were fluent in Hebrew. Control and experimental groups were defined using participants’ self-reported medical conditions, and diagnoses were not verified via medical records. The final sample included 348 men; of them, 123 (31%) were excluded due to missing data. The final sample comprised 225 men, of whom 102 (45%) had reported being diagnosed with FMS and 123 were HPs aged 18–75.

2.1. Measures

Participant background data included weight and height, age, marital status, and number of children. BMI was calculated using participants’ reported weight and height. Men who indicated a diagnosis of FMS also reported how long they had been living with the condition.
Depressive symptoms were measured with the 9-item Patient Health Questionnaire (PHQ-9) [36,37]. Each item ranges from 0 (not at all) to 3 (nearly every day). All scores are added together to obtain a global score, which ranges from 0 to 27, with higher scores indicating higher levels of depression. Internal consistency of the PHQ-9 in the current study was satisfactory (ω = 0.91).
Generalized anxiety was assessed using the 7-item Generalized Anxiety Disorder Scale (GAD-7) [38,39]. Items are rated from 0 (not at all) to 3 (nearly every day) and added together to yield a total score ranging from 0 to 21, with higher scores indicating higher levels of anxiety; internal consistency in the current study was satisfactory (ω = 0.93).
The Body Appreciation Scale-2 (BAS-2) [17,40] is a 10-item measure assessing acceptance, respect, and care for one’s body, as well as protection from unrealistic beauty standards. Items are rated from 1 (never) to 5 (always) and averaged to create a mean score, with higher values indicating greater body appreciation (ω = 0.93).
The Masculine Self-Esteem Scale (MSES) [41] is a self-report questionnaire for adult men assessing perceptions of masculinity. It includes eight items rated on a scale from 1 (strongly disagree) to 5 (strongly agree). Higher scores indicate lower masculinity self-esteem. Translated into Hebrew using the back-translation method, it showed satisfactory internal consistency in this study (ω = 0.93).
The Chronic-Illness-Related Shame Scale (CISS) [42] is a seven-item self-report measure assessing shame related to chronic illness. Items are rated on a Likert scale from 0 (not at all true) to 4 (very true), with higher scores indicating greater shame. Translated into Hebrew using the back-translation method [43], it showed satisfactory internal consistency in this study (ω = 0.88).
The Short-Form McGill Pain Questionnaire (SF-MPQ) [44,45] is a 15-item adjective checklist assessing perceived pain intensity, with items rated from 0 (none) to 3 (severe), and includes two single-item measures of present pain. For this study, the two present-pain items were combined, with higher scores indicating greater pain perception; internal consistency in the current sample was satisfactory (ω = 0.98).

2.2. Statistical Analysis

Descriptive statistics are presented as M (SD) for numeric measures and N (%) for categorical ones. Group differences were tested using one-way ANOVA and Chi-square tests. Pearson correlations were calculated between the main study variables. Process model 6 [46] was used to test hypotheses H1c and H2b, and model 1was used to test the follow-up moderation model. Power analysis was performed using G*Power 3.1.9.4. Results showed that the sample size used was sufficient for detecting a medium effect (f2 = 0.15) with a probability of more than 99%.

3. Results

Analysis of sample demographics showed that men with FMS are older, less educated, and less likely to be in relationships than the control group (Table 1). These background variables correlate with depression, and all but relationship status correlate with anxiety (Table 2). Of them, age will be controlled for in all further analysis, as it correlates with the other covariates. However, including it as a covariate yielded essentially similar results to those obtained when no covariate was included.

3.1. Hypothesis 1: Group Differences

  • Hypothesis 1a
In accordance with hypothesis 1a, the results indicate that men with FMS reported on average more symptoms of anxiety and depression, lower body appreciation and compromised masculinity (Table 3).
  • Hypothesis 1b
Table 4 indicates significant correlations among all primary study variables. The hypothesis was thus supported by the data.
  • Hypothesis 1c
In predicting depression (Figure 3a), we found that all direct paths were significant, as well as three indirect paths: through body appreciation (Beta = 0.08, 95%CI = [0.02, 0.16]), through compromised masculine identity (Beta = 0.52, 95%CI = [0.34, 0.70]), and through body appreciation followed by compromised masculine identity (Beta = 0.09, 95%CI = [0.04, 0.15]).
In predicting anxiety (Figure 3b), we found that all direct paths were significant except for the direct path between body appreciation and anxiety. Additionally, we found three indirect paths: through body appreciation (Beta = 0.08, 95%CI = [0.02, 0.16]), through compromised masculine identity (Beta = 0.52, 95%CI = [0.34, 0.70]), and through body appreciation followed by compromised masculine identity (Beta = 0.09, 95%CI = [0.04, 0.15]).

3.2. Hypothesis 2: Among Men with FMS

Age at symptom onset and diagnosis were not correlated with psychological distress; therefore, no covariates were included in subsequent models (Table 5).
  • Hypothesis 2a
As hypothesized, among men with FMS, PD was positively related to pain, illness-related shame and sense of compromised masculinity (Table 6). However, in contrast to our hypothesis, body appreciation was not correlated with pain and PD.
  • Hypothesis 2b
As there was no association between body appreciation and either PD or pain, body appreciation was removed from the mediation model. The revised model is presented in Figure 4a.
The model predicting depression (Figure 4b) revealed, in addition to the direct path, two indirect paths: through compromised masculine identity (Beta = 0.05, 95%CI = [0.004, 0.11]) and through shame followed by compromised masculine identity (Beta = 0.04, 95%CI = [0.005, 0.09]).
Similarly, the model predicting anxiety (Figure 4c) revealed, in addition to the direct path, identical indirect paths: through compromised masculine identity (Beta = 0.05, 95%CI = [0.004, 0.11]) and through shame followed by compromised masculine identity (Beta = 0.04, 95%CI = [0.005, 0.09]).

3.3. Additional Findings

The lack of correlation between body appreciation and PD, contrary to the literature identifying it as a protective factor, prompted us to examine whether its role differs between men with FMS and the control group. This was tested using the moderation model shown in Figure 5.
A significant interaction emerged between FMS and body appreciation in predicting depression. Among controls, body appreciation correlated negatively with depression (r = −0.48, p < 0.001), whereas no significant association was found in the FMS group (r = −0.18, ns). A similar, though non-significant, pattern was observed for anxiety. These results suggest that body appreciation does not operate as a protective factor among FMS patients, consistent with their elevated levels of PD.

4. Discussion

Fibromyalgia is more prevalent in women, and psychological research has therefore focused largely on women [6]. This study addresses the resulting gap by examining gender-specific mechanisms of distress in men with FMS. Results showed that men with fibromyalgia reported significantly higher depression and anxiety, lower body appreciation, and reduced masculine identity. These findings align with prior evidence of elevated distress in this population [10,11] and may be further exacerbated by the long delay between symptom onset and diagnosis, which in our sample averaged 4–5 years and may contribute to the “double burden of credibility” [6]. The present findings further highlight body image and masculine identity as key vulnerability factors. Mediation analysis indicated that body appreciation mediates the association between fibromyalgia and psychological distress, echoing findings in women [13,14]. This suggests that body appreciation may operate as a broader mechanism influencing mental health in fibromyalgia, although the absence of its protective role among men with FMS, discussed below, warrants cautious interpretation.
Masculine identity emerged as a key mechanism in both mediation models. When comparing men with FMS to HPs, reduced body appreciation predicted weakened masculine identity, which in turn heightened depression and anxiety. This aligns with evidence that chronic pain and functional limits prompt ongoing renegotiation of identity [12] and reduced body appreciation in FMS [13]. It thus may be assumed that participants’ loss of physical capability threatens hegemonic masculine norms, prompts ongoing identity renegotiation and increases psychological distress. In the FMS-only model, illness-related shame and compromised masculinity were the strongest pathways to psychological distress, with body appreciation no longer contributing. This pattern reflects the central role of shame in chronic illness, where loss of autonomy and a sense of bodily failure frequently lead to depression and anxiety [34]. Threats to masculine identity organized around strength, competence, and independence further amplify distress [25], and qualitative studies illustrate how these pressures interact with internalized stigma and role performance shame [6,12]. These dynamics are embedded in cultural contexts in which traditional masculine norms that emphasize physical capability, protection, and breadwinning remain highly salient [47,48]. Such expectations amplify stigma, inhibit symptom disclosure, discourage help seeking, and pressure men to persevere despite pain, thereby exacerbating distress [7,29].
The contrast between intra-group and inter-group analyses poses a theoretical challenge. Among HPs, higher body appreciation was strongly linked to better psychological wellbeing, but this association was absent in men with FMS. Moderation analysis indicated that body appreciation failed to buffer PD in men with FMS, contradicting evidence that it generally serves as a protective factor across chronic conditions [17]. Fibromyalgia’s invisible yet pervasive symptoms may disrupt the link between body appreciation and psychological wellbeing by fostering experiences of the body as unreliable or alien [12]. This disruption is reinforced by the well-documented cycle linking pain and distress in FMS: pain impairs functioning and social roles, heightening depression and anxiety, while distress intensifies pain through hypervigilance and catastrophizing [49,50]. Within this cycle, any protective effect of body appreciation may be limited [51]. Several factors may account for the missing effect. The high and persistent symptom burden of FMS can exceed the buffering capacity of psychological resources [51,52], while the unpredictability of symptoms may suppress body appreciation to a level that creates a floor effect [53]. Measurement issues may also play a role, as common body appreciation scales underrepresent bodily trust and functionality, which may be especially relevant for men with FMS. In addition, restricted variability in depression and anxiety scores may further reduce observable correlations [51].

Limitations

The findings should be interpreted considering several limitations. First, the cross-sectional design prevents causal inference. Second, illness status was self-reported rather than clinically verified; variation in diagnostic source and criteria may have increased misclassification and heterogeneity in the fibromyalgia group due to misunderstanding, recall error, or symptom overlap, potentially biasing observed associations. Third, online recruitment may have introduced selection bias, as individuals in support groups often report greater illness burden [54]. Fourth, the sample included only Israeli participants. Fifth, comorbid chronic conditions were not assessed and may have influenced the findings. Sixth, 31% of participants did not complete the survey. Seventh, future studies may benefit from including the Functionality Appreciation Scale (FAS) [55], as the BAS-2 may be susceptible to floor effects in chronic-pain populations. Finally, the study focused on a limited set of mediators, leaving other relevant psychological and social mechanisms, such as illness perceptions, coping style, and social support, for future research.
Despite these limitations, the findings offer clear implications for practice. Clinical care should address identity and role disruption alongside symptom management, helping men develop a broader and more flexible sense of masculinity in which “strength” includes persistence, timely help seeking, caregiving, and values-based action, rather than forms of vulnerability that conflict with internalized norms [56]. Body-focused interventions should prioritize functionality, confidence in safe movement, pacing, and interoceptive awareness and trust rather than appearance-based acceptance [57,58], and may be strengthened by acceptance- and commitment-based approaches that explicitly target shame and values guided action [59]. A multidisciplinary approach that combines management of pain, sleep, and mood with gender-sensitive psychoeducation and body-oriented methods may reduce shame, lessen identity threat, increase engagement, and improve psychological wellbeing [7,12]. During assessment, clinicians can complement the standard pain history by asking, “Beyond the pain itself, what bothers you most about having fibromyalgia?” or “How has this affected the role you mentioned?” to identify shame, avoidance, and identity threats that may maintain distress.
Overall, this study deepens understanding of how fibromyalgia contributes to psychological distress in men by highlighting the central role of identity and social role disruption. The findings underscore the need for gender-sensitive models of chronic pain that recognize how illness differently shapes masculine and feminine identity. Future research should further examine the interplay between functionality and functionality appreciation to support the development of more tailored and effective psychological interventions.

Author Contributions

Conceptualization, S.G., R.A. and S.L.; methodology, S.G., R.A. and S.L.; formal analysis, S.L.; data curation, R.A. and S.L.; writing—original draft preparation, S.G., R.A. and S.L.; writing—review and editing, S.G., R.A. and S.L. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board (IRB) of The Academic College of Tel-Aviv Yaffo (# 2023315 on 16 December 2023).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available due to ethical restrictions.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
FMSFibromyalgia syndrome
HPsHealthy peers

References

  1. Borchers, A.T.; Gershwin, M.E. Fibromyalgia: A critical and comprehensive review. Clin. Rev. Allergy Immunol. 2015, 49, 100–151. [Google Scholar] [CrossRef] [PubMed]
  2. Gormsen, L.; Rosenberg, R.; Bach, F.W.; Jensen, T.S. Depression, anxiety, health-related quality of life and pain in patients with chronic fibromyalgia and neuropathic pain. Eur. J. Pain 2010, 14, 127.e1–127.e8. [Google Scholar] [CrossRef] [PubMed]
  3. Queiroz, L.P. Worldwide epidemiology of fibromyalgia. Curr. Pain Headache Rep. 2013, 17, 356. [Google Scholar] [CrossRef] [PubMed]
  4. Wolfe, F.; Walitt, B.; Perrot, S.; Rasker, J.J.; Häuser, W. Fibromyalgia diagnosis and biased assessment: Sex, prevalence and bias. PLoS ONE 2018, 13, e0203755. [Google Scholar] [CrossRef]
  5. Yunus, M.B. Gender differences in fibromyalgia and other related syndromes. J. Gend-Specif. Med. 2002, 5, 42–47. [Google Scholar]
  6. Conversano, C.; Ciacchini, R.; Orrù, G.; Bazzichi, M.L.; Gemignani, A.; Miniati, M. Gender differences on psychological factors in fibromyalgia: A systematic review on the male experience. Clin. Exp. Rheumatol. 2021, 39, 174–185. [Google Scholar] [CrossRef]
  7. Samulowitz, A.; Gremyr, I.; Eriksson, E.; Hensing, G. “Brave men” and “emotional women”: A theory-guided literature review on gender bias in health care and gendered norms towards patients with chronic pain. Pain Res. Manag. 2018, 2018, 6358624. [Google Scholar] [CrossRef]
  8. Coady, A.; Godard, R.; Holtzman, S. Understanding the link between pain invalidation and depressive symptoms: The role of shame and social support in people with chronic pain. J. Health Psychol. 2024, 29, 52–64. [Google Scholar] [CrossRef]
  9. Muraleetharan, D.; Fadich, A.; Stephenson, C.; Garney, W. Understanding the impact of fibromyalgia on men: Findings from a nationwide survey. Am. J. Mens Health 2018, 12, 952–960. [Google Scholar] [CrossRef]
  10. Ruschak, I.; Toussaint, L.; Rosselló, L.; Martín, C.A.; Fernández-Sáez, J.; Montesó-Curto, P. Symptomatology of fibromyalgia syndrome in men: A mixed-method pilot study. Int. J. Env. Res. Public Health 2022, 19, 1724. [Google Scholar] [CrossRef]
  11. Henao-Pérez, M.; López-Medina, D.C.; Arboleda, A.; Monsalve, S.B.; Zea, J.A. Patients with fibromyalgia, depression, and/or anxiety and sex differences. Am. J. Mens Health 2022, 16, 15579883221110351. [Google Scholar] [CrossRef]
  12. Sallinen, M.; Mengshoel, A.M.; Solbrække, K.N. “I can’t have it; I am a man. A young man!”—Men, fibromyalgia and masculinity in a Nordic context. Int. J. Qual. Stud. Health Well-Being 2019, 14, 1676974. [Google Scholar] [CrossRef] [PubMed]
  13. Geller, S.; Levy, S.; Mann, Y.; Sela, S.; Rafenberg, G.; Avitsur, R. Body appreciation as a protective factor in women with fibromyalgia: Associations between pain perception, social comparison and psychological distress. Clin. Exp. Rheumatol. 2022, 40, 1166–1174. [Google Scholar] [CrossRef] [PubMed]
  14. Levy, S.; Ohayon, S.; Avitsur, R.; Geller, S. Psychological distress in women with fibromyalgia: The roles of body appreciation, self-compassion, and self-criticism. Int. J. Behav. Med. 2025, 32, 351–359. [Google Scholar] [CrossRef] [PubMed]
  15. Cash, T.F. Body image: Past, present, and future. Body Image 2004, 1, 1–5. [Google Scholar] [CrossRef]
  16. Alleva, J.M.; Tylka, T.L. Body functionality: A review of the literature. Body Image 2021, 36, 149–171. [Google Scholar] [CrossRef]
  17. Tylka, T.L.; Wood-Barcalow, N.L. The Body Appreciation Scale-2: Item refinement and psychometric evaluation. Body Image 2015, 12, 53–67. [Google Scholar] [CrossRef]
  18. Ettridge, K.; Scharling-Gamba, K.; Miller, C.; Roder, D.; Prichard, I. Body image and quality of life in women with breast cancer: Appreciating the body and its functionality. Body Image 2022, 40, 92–102. [Google Scholar] [CrossRef]
  19. Geller, S.; Levy, S.; Ashkeloni, S.; Roeh, B.; Sbiet, E.; Avitsur, R. Predictors of psychological distress in women with endometriosis: The role of multimorbidity, body image, and self-criticism. Int. J. Environ. Res. Public. Health 2021, 18, 3453. [Google Scholar] [CrossRef]
  20. Akkaya, N.; Akkaya, S.; Atalay, N.S.; Balci, C.S.; Sahin, F. Relationship between the body image and level of pain, functional status, severity of depression, and quality of life in patients with fibromyalgia syndrome. Clin. Rheumatol. 2012, 31, 983–988. [Google Scholar] [CrossRef]
  21. Menten, L.A.; Franco, K.F.M.; Franco, Y.R.S.; Miyamoto, G.C.; Reis, F.J.J.; Cabral, C.M.N. Do patients with fibromyalgia have body image and tactile acuity distortion? Pain Pract. 2022, 22, 678–687. [Google Scholar] [CrossRef] [PubMed]
  22. Boyington, J.E.; Schoster, B.; Callahan, L.F. Comparisons of body image perceptions of a sample of Black and White women with rheumatoid arthritis and fibromyalgia in the US. Open Rheumatol. J. 2015, 9, 1–7. [Google Scholar] [CrossRef] [PubMed]
  23. Paulson, M.; Danielson, E.; Söderberg, S. Struggling for a tolerable existence: The meaning of men’s lived experiences of living with pain of fibromyalgia type. Qual. Health Res. 2002, 12, 238–249. [Google Scholar] [CrossRef] [PubMed]
  24. Markey, C.H.; Dunaev, J.L.; August, K.J. Body image experiences in the context of chronic pain: Associations among perceptions of pain, body dissatisfaction, and positive body image. Body Image 2020, 32, 103–110. [Google Scholar] [CrossRef]
  25. Connell, R.W.; Messerschmidt, J.W. Hegemonic masculinity: Rethinking the concept. Gend. Soc. 2005, 19, 829–859. [Google Scholar] [CrossRef]
  26. Connell, R.W. Gender and Power: Society, the Person and Sexual Politics; University of California Press: Palo Alta, CA, USA, 1987. [Google Scholar]
  27. Pearson, K.; Pini, B. Men, chronic illness and the negotiation of masculinity. In Disability and Masculinities: Corporeality, Pedagogy and the Critique of Otherness; Palgrave Macmillan: London, UK, 2017; pp. 173–190. [Google Scholar]
  28. Bernardes, S.F.; Lima, M.L. Being less of a man or less of a woman: Perceptions of chronic pain patients’ gender identities. Eur. J. Pain 2010, 14, 194–203. [Google Scholar] [CrossRef]
  29. Blackbeard, D.; Aldous, C. Chronic pain and masculine identity: Life-world interviews with men at a South African Pain Clinic. Int. J. Qual. Stud. Health Well-Being 2021, 16, 1970303. [Google Scholar] [CrossRef]
  30. Tangney, J.P.; Dearing, R.L. Shame and Guilt; Guilford Press: New York, NY, USA, 2003. [Google Scholar]
  31. Andrews, B.; Brewin, C.R.; Rose, S.; Kirk, M. Predicting PTSD symptoms in victims of violent crime: The role of shame, anger, and childhood abuse. J. Abnorm. Psychol. 2000, 109, 69–73. [Google Scholar] [CrossRef]
  32. Robinaugh, D.J.; Mcnally, R.J. Autobiographical memory for shame- or guilt-provoking events: Association with psychological symptoms. Behav. Res. Ther. 2010, 48, 646–652. [Google Scholar] [CrossRef]
  33. Smith, J.A.; Osborn, M. Pain as an assault on the self: An interpretative phenomenological analysis of the psychological impact of chronic benign low back pain. Psychol. Health 2007, 22, 517–534. [Google Scholar] [CrossRef]
  34. Turner-Cobb, J.M.; Michalaki, M.; Osborn, M. Self-conscious emotions in patients suffering from chronic musculoskeletal pain: A brief report. Psychol. Health 2015, 30, 495–501. [Google Scholar] [CrossRef]
  35. Earnshaw, V.A.; Watson, R.J.; Eaton, L.A.; Brousseau, N.M.; Laurenceau, J.P.; Fox, A.B. Integrating time into stigma and health research. Nat. Rev. Psychol. 2022, 1, 236–247. [Google Scholar] [CrossRef] [PubMed]
  36. Kroenke, K.; Spitzer, R.L.; Williams, J.B.W. The PHQ-9. J. Gen. Intern. Med. 2001, 16, 606–613. [Google Scholar] [CrossRef] [PubMed]
  37. Geulayov, G.; Jungerman, T.; Moses, S.; Friedman, N.; Miron, R.; Gross, R. Validation of the Hebrew version of the PHQ-9, a screening instrument for depression in primary care. Isr. J. Psychiatry 2009, 46, 45–50. [Google Scholar]
  38. Spitzer Rl Kroenke, K.; Williams, J.B.W.; Löwe, B. A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch. Intern. Med. 2006, 166, 1092–1097. [Google Scholar] [CrossRef]
  39. Palgi, S. (Ed.) Self-Report Questionnaire Compendium; Israel, Ministry of Health, Professional Committee for Clinical Psychology: Tel Aviv-Jaffa, Israel, 2019. (In Hebrew)
  40. Geller, S.; Handelzalts, J.E.; Levy, S.; Boxer, N.; Todd, J.; Swami, V. An examination of the factor structure and preliminary assessment of the psychometric properties of a Hebrew translation of the Body Appreciation Scale-2 (BAS-2). Body Image 2020, 34, 145–154. [Google Scholar] [CrossRef]
  41. Clark, J.A.; Bokhour, B.G.; Inui, T.S.; Silliman, R.A.; Talcott, J.A. Measuring patients’ perceptions of the outcomes of treatment for early prostate cancer. Med. Care 2003, 41, 923–936. [Google Scholar] [CrossRef]
  42. Trindade, I.A.; Ferreira, C.; Pinto-Gouveia, J. Chronic illness-related shame: Development of a new scale and novel approach for IBD patients’ depressive symptomatology. Clin. Psychol. Psychother. 2016, 24, 255–263. [Google Scholar] [CrossRef]
  43. Brislin, R.W. Back-translation for cross-cultural research. J. Cross Cult. Psychol. 1970, 1, 185–216. [Google Scholar] [CrossRef]
  44. Melzack, R. The short-form McGill Pain Questionnaire. Pain 1987, 30, 191–197. [Google Scholar] [CrossRef]
  45. Margalit, D.; Ben Har, L.; Brill, S.; Vatine, J.J. Complex regional pain syndrome, alexithymia, and psychological distress. J. Psychosom. Res. 2014, 77, 273–277. [Google Scholar] [CrossRef] [PubMed]
  46. Hayes, A.F. Partial, conditional, and moderated moderated mediation: Quantification, inference, and interpretation. Commun. Monogr. 2018, 85, 4–40. [Google Scholar] [CrossRef]
  47. Geller, S.; Levy, S.; Hyman, O.; Jenkins, P.L.; Abu-Abeid, S.; Goldzweig, G. Body image, emotional eating and psychological distress among bariatric surgery candidates in Israel and the United States. Nutrients 2020, 12, 490. [Google Scholar] [CrossRef] [PubMed]
  48. Hirsch, D.; Kachtan, D.G. Is “hegemonic masculinity” hegemonic as masculinity? Two Israeli case studies. Men Masc. 2018, 21, 687–708. [Google Scholar] [CrossRef]
  49. Uçar, M.; Sarp, Ü.; Karaaslan, Ö.; Gül, A.I.; Tanik, N.; Arik, H.O. Health anxiety and depression in patients with fibromyalgia syndrome. J. Int. Med. Res. 2015, 43, 679–685. [Google Scholar] [CrossRef]
  50. Martinez-Calderon, J.; Struyf, F.; Meeus, M.; Luque-Suarez, A. The association between pain beliefs and pain intensity and/or disability in people with shoulder pain: A systematic review. Musculoskelet. Sci. Pract. 2018, 37, 29–57. [Google Scholar] [CrossRef]
  51. Clauw, D.J. Fibromyalgia: A clinical review. JAMA 2014, 311, 1547–1555. [Google Scholar] [CrossRef]
  52. Bennett, R.M.; Friend, R.; Jones, K.D.; Ward, R.; Han, B.K.; Ross, R.L. The Revised Fibromyalgia Impact Questionnaire (FIQR): Validation and psychometric properties. Arthritis Res. Ther. 2009, 11, R120. [Google Scholar] [CrossRef]
  53. McDermid, A.J.; Rollman, G.B.; McCain, G.A. Generalized hypervigilance in fibromyalgia: Evidence of perceptual amplification. Pain 1996, 66, 133–144. [Google Scholar] [CrossRef]
  54. Armour, M.; Sinclair, J.; Chalmers, K.J.; Smith, C.A. Self-management strategies amongst Australian women with endometriosis: A national online survey. BMC Complement. Altern. Med. 2019, 19, 17. [Google Scholar] [CrossRef]
  55. Alleva, J.M.; Tylka, T.L.; Kroon Van Diest, A.M. The Functionality Appreciation Scale (FAS): Development and psychometric properties in U.S. community women and men. Body Image 2017, 23, 28–44. [Google Scholar] [CrossRef]
  56. Galdas, P.M.; Cheater, F.; Marshall, P. Men and health help-seeking behaviour: Literature review. J. Adv. Nurs. 2005, 49, 616–623. [Google Scholar] [CrossRef]
  57. Alleva, J.M.; Diedrichs, P.C.; Halliwell, E.; Peters, M.L.; Dures, E.; Stuijfzand, B.G.; Rumsey, N. More than my RA: A randomized trial investigating body image improvement among women with rheumatoid arthritis using a functionality-focused intervention program. J. Consul. Clin. Psychol. 2018, 86, 666–676. [Google Scholar] [CrossRef]
  58. Mehling, W.E.; Price, C.; Daubenmier, J.J.; Acree, M.; Bartmess, E.; Stewart, A. The Multidimensional Assessment of Interoceptive Awareness (MAIA). PLoS ONE 2012, 7, e48230. [Google Scholar] [CrossRef]
  59. Lillis, J.; Hayes, S.C.; Bunting, K.; Masuda, A. Teaching acceptance and mindfulness to improve the lives of the obese: A preliminary test of a theoretical model. Ann. Behav. Med. 2009, 37, 58–69. [Google Scholar] [CrossRef]
Figure 1. Hypothesized model for group comparison.
Figure 1. Hypothesized model for group comparison.
Healthcare 14 00606 g001
Figure 2. Hypothesized model among men with FMS.
Figure 2. Hypothesized model among men with FMS.
Healthcare 14 00606 g002
Figure 3. Mediation model for testing the relationship between FMS and depression (a) and the relationship between FMS and anxiety (b). Numbers above the lines are standardized path coefficients. Numbers above variable names are multiple squared correlations. ** p < 0.01.
Figure 3. Mediation model for testing the relationship between FMS and depression (a) and the relationship between FMS and anxiety (b). Numbers above the lines are standardized path coefficients. Numbers above variable names are multiple squared correlations. ** p < 0.01.
Healthcare 14 00606 g003
Figure 4. Revised mediation model for men with FMS (a). Mediation model for predicting depression among men with (b). Mediation model for predicting anxiety among men with FMS (c). Numbers above the lines are standardized path coefficients. Numbers above variable names are multiple squared correlations. ** p < 0.01.
Figure 4. Revised mediation model for men with FMS (a). Mediation model for predicting depression among men with (b). Mediation model for predicting anxiety among men with FMS (c). Numbers above the lines are standardized path coefficients. Numbers above variable names are multiple squared correlations. ** p < 0.01.
Healthcare 14 00606 g004
Figure 5. The proposed moderating role of health status in the link between body appreciation and PD.
Figure 5. The proposed moderating role of health status in the link between body appreciation and PD.
Healthcare 14 00606 g005
Table 1. Sample demographics and group comparison of background variables.
Table 1. Sample demographics and group comparison of background variables.
FMS (N = 102)Control (N = 123)F(1, 223) 2(1)
M (SD)N (%)M (SD)N (%)
Age39.8 (9.3) 33.3 (10.0) 25.2 **
Years of Schooling13.7 (2.6) 15.1 (3.0) 14.1 **
Number of Children1.7 (1.7) 1.3 (1.7) 3.7
In a Relationship (yes) 63 (62) 95 (77) 5.9 *
* p < 0.05, ** p < 0.01.
Table 2. Correlations between the background characteristics and the outcome variables.
Table 2. Correlations between the background characteristics and the outcome variables.
DepressionAnxiety
Age0.27 **0.29 **
Years of Schooling−0.29 **−0.22 **
Number of Children0.17 **0.20 **
In a Relationship (yes)0.18 **0.06
** p < 0.01.
Table 3. Group comparison in the main study variables. Numbers in the cells are M (SD).
Table 3. Group comparison in the main study variables. Numbers in the cells are M (SD).
FMS (N = 102)Control (N = 123)F(1, 223)
Depression28.0 (5.2)15.8 (4.7)345.1 **
Anxiety21.5 (5.1)12.2 (4.1)232.4 **
Body Appreciation3.1 (0.9)3.7 (0.9)33.9 **
Compromised Masculine Identity3.3 (1.0)1.6 (0.7)234.2 **
** p < 0.01.
Table 4. Correlations between the main study variables.
Table 4. Correlations between the main study variables.
DepressionAnxietyBody Appreciation
Anxiety0.82 **
Body Appreciation−0.48 **−0.41 **
Compromised Masculine Identity0.79 **0.79 **−0.50 **
** p < 0.01.
Table 5. Descriptive statistics for illness-related variables (N = 102).
Table 5. Descriptive statistics for illness-related variables (N = 102).
M (SD)Range
Pain16.2 (15.3)0.0–45.0
Illness-related Shame3.3 (1.1)1.0–5.0
Age at Symptom Onset31.4 (9.5)14.0–56.0
Age at Diagnosis35.9 (9.9)16.0–63.0
Table 6. Correlations between the main study variables and illness-related variables among men with FMS.
Table 6. Correlations between the main study variables and illness-related variables among men with FMS.
12345
Depression
Anxiety0.23 **
Body Appreciation−0.18−0.13
Compromised Masculine Identity 0.48 **0.62 **−0.31 **
Illness-related Shame0.34 **0.52 **−0.24 *0.65 **
Pain0.60 **0.55 **0.180.38 **0.28 **
* p < 0.05, ** p < 0.01.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Geller, S.; Levy, S.; Avitsur, R. Masculine Identity, Body Image and Illness-Related Shame: Pathways to Psychological Distress in Men with Fibromyalgia. Healthcare 2026, 14, 606. https://doi.org/10.3390/healthcare14050606

AMA Style

Geller S, Levy S, Avitsur R. Masculine Identity, Body Image and Illness-Related Shame: Pathways to Psychological Distress in Men with Fibromyalgia. Healthcare. 2026; 14(5):606. https://doi.org/10.3390/healthcare14050606

Chicago/Turabian Style

Geller, Shulamit, Sigal Levy, and Ronit Avitsur. 2026. "Masculine Identity, Body Image and Illness-Related Shame: Pathways to Psychological Distress in Men with Fibromyalgia" Healthcare 14, no. 5: 606. https://doi.org/10.3390/healthcare14050606

APA Style

Geller, S., Levy, S., & Avitsur, R. (2026). Masculine Identity, Body Image and Illness-Related Shame: Pathways to Psychological Distress in Men with Fibromyalgia. Healthcare, 14(5), 606. https://doi.org/10.3390/healthcare14050606

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop